V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218010 | 20179978 | 1.8 | 88.7 | null | 2019-10-31 | 2019-11-25 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100660882 |
| 20218052 | 20179979 | 1.63 | 63.4 | 03 | 2017-11-13 | 2018-07-13 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100032040 |
| 20218111 | 20179980 | 1.55 | 71.2 | Palliative (P) | 2016-11-13 | 2017-04-27 | Trastuzumab 21 day loading dose | N | null | TRASTUZUMAB | 100856685 |
| 20218154 | 20179981 | 1.68 | 67.1 | Palliative (P) | null | 2017-07-16 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | IRINOTECAN + MDG | 100750336 |
| 20218204 | 20179982 | 1.72 | 81 | Palliative (P) | null | 2019-05-14 | Irinotecan + Modified De Gramont | N | N | IRINOTECAN + MDG | 100223862 |
| 20218280 | 20179983 | null | 87 | Palliative (P) | 2020-12-12 | 2021-01-25 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100501565 |
| 20218484 | 20179984 | 1.46 | 84.5 | null | 2018-12-19 | 2018-12-19 | Irinotecan + Modified De Gramont | 02 | null | IRINOTECAN | 100819810 |
| 20218493 | 20179985 | 1.95 | 74.3 | Palliative (P) | null | 2019-04-26 | Irinotecan 14day | 02 | N | IRINOTECAN | 100056429 |
| 20218650 | 20179987 | 1.91 | 70.1 | null | 2021-01-18 | 2021-02-10 | Irinotecan | 02 | null | IRINOTECAN | 101314823 |
| 20218764 | 20179988 | 1.57 | 41 | null | 2019-11-08 | 2019-11-21 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101781052 |
| 20219015 | 20179989 | 1.79 | 109.3 | Palliative (P) | 2018-09-13 | 2018-09-17 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | IRINOTECAN + MDG | 100687325 |
| 20219051 | 20179990 | 1.72 | 82.6 | Palliative (P) | 2018-12-18 | 2018-12-18 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 101650398 |
| 20219081 | 20179991 | 1.78 | 80.4 | null | 2018-10-06 | 2018-11-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100398303 |
| 20219337 | 20179992 | 1.55 | 46.8 | Palliative (P) | 2021-07-10 | 2021-07-16 | Irinotecan 14day | N | null | IRINOTECAN | 100572151 |
| 20219389 | 20179993 | 1.55 | 64.3 | Palliative (P) | 2016-06-06 | 2016-06-13 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | Y | IRINOTECAN | 100561204 |
| 20219400 | 20179994 | 1.75 | 80.9 | Palliative (P) | 2022-02-11 | 2022-02-14 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 101628008 |
| 20219485 | 20179995 | 1.67 | 40.1 | Curative (C) | 2019-12-14 | 2020-05-04 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101147109 |
| 20219516 | 20179996 | 1.74 | 78 | Palliative (P) | 2019-11-07 | 2019-11-14 | Irinotecan 14day | 02 | N | IRINOTECAN | 100562788 |
| 20219535 | 20179997 | 1.81 | 56.6 | Palliative (P) | null | 2016-06-25 | Irinotecan 14day | 02 | N | IRINOTECAN | 100715724 |
| 20219645 | 20179998 | 1.54 | null | null | 2019-01-18 | 2019-01-25 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 100984056 |
| 20219732 | 20179999 | 1.67 | 67.2 | null | 2019-05-30 | 2019-06-13 | Irinotecan + Modified De Gramont | 02 | null | IRINOTECAN + MDG | 101424888 |
| 20219865 | 20180000 | 1.76 | 75.9 | Palliative (P) | 2020-08-22 | 2020-08-22 | FLUOROURACIL + IRINOTECAN | 02 | null | IRINOTECAN + MDG | 100037819 |
| 20219912 | 20180002 | 1.6 | 63.6 | null | 2019-12-01 | 2020-10-25 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100171984 |
| 20220070 | 20180003 | 0 | 43.4 | Palliative (P) | null | 2021-09-25 | Capecitabine (14 days)+Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101607846 |
| 20220091 | 20180004 | 1.79 | 68 | null | 2021-12-09 | 2021-12-28 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100566479 |
| 20220163 | 20180005 | 1.72 | 77.2 | Palliative (P) | 2020-01-16 | 2020-02-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101768239 |
| 20220173 | 20180006 | 1.59 | 52.6 | null | 2018-10-09 | 2018-10-23 | Cape+Cisplatin+Trastuzumab Main | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100927755 |
| 20220179 | 20180007 | 1.8 | 51.35 | Palliative (P) | 2019-02-21 | 2019-02-28 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101150997 |
| 20220243 | 20180008 | 1.51 | 70 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-05 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100340220 |
| 20220299 | 20180009 | 1.72 | 55.8 | null | 2019-06-05 | 2019-06-18 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100788704 |
| 20220334 | 20180010 | 1.68 | 69 | null | 2017-08-09 | 2018-01-12 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101443742 |
| 20220352 | 20180011 | 1.64 | 98 | Palliative (P) | 2017-12-26 | 2018-09-14 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101225375 |
| 20220397 | 20180012 | 1.7 | 65.7 | null | 2017-12-31 | 2018-08-17 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100387687 |
| 20220624 | 20180013 | 1.55 | 86.1 | Palliative (P) | 2020-02-06 | 2020-02-12 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100526319 |
| 20220745 | 20180014 | 1.76 | 69.5 | Curative (C) | null | 2019-05-04 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100231340 |
| 20220747 | 20180015 | 1.55 | 70.8 | null | 2018-10-27 | 2018-11-11 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101606636 |
| 20220800 | 20180016 | 1.73 | 109.4 | null | 2019-10-13 | 2020-06-05 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100941969 |
| 20220864 | 20180018 | 1.76 | 72.2 | null | 2019-01-13 | 2019-01-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100086352 |
| 20220877 | 20180019 | 1.62 | 53.05 | Adjuvant (A) | 2018-01-28 | 2018-02-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100992867 |
| 20221057 | 20180020 | 1.7 | 68.8 | Palliative (P) | 2021-08-14 | 2021-08-21 | null | 2 | N | ECX | 100264853 |
| 20221103 | 20180021 | 1.7 | 73.3 | null | 2016-06-21 | 2016-07-24 | null | 02 | null | NIVOLUMAB | 101482232 |
| 20221118 | 20180022 | null | null | null | null | 2017-03-26 | null | N | null | CARBOPLATIN + ETOPOSIDE | 100595490 |
| 20221185 | 20180023 | 1.69 | 103 | Palliative (P) | null | 2017-05-04 | Panitumumab | N | N | PANITUMUMAB | 101382602 |
| 20221297 | 20180024 | 1.58 | 71.8 | null | 2018-03-25 | 2018-04-27 | null | null | null | ECX | 100123939 |
| 20221413 | 20180025 | 1.63 | 75.6 | null | 2018-09-09 | 2018-09-24 | null | 02 | null | PANITUMUMAB | 100575563 |
| 20221450 | 20180026 | null | null | Palliative (P) | null | 2018-08-28 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101030491 |
| 20221483 | 20180027 | 1.87 | 71.4 | Palliative (P) | 2021-11-19 | 2021-12-24 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100896888 |
| 20221872 | 20180028 | 1.7 | 77 | Palliative (P) | 2018-06-02 | 2018-06-24 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101483998 |
| 20221911 | 20180029 | 1.64 | 67 | Neo-adjuvant (N) | 2017-07-03 | 2017-07-04 | ECX | 02 | Y | ECX | 100526766 |
| 20221977 | 20180030 | 1.77 | 59.1 | null | 2015-11-11 | 2016-10-02 | null | 02 | null | ECX | 100127787 |